Trimipramine

- TRADE NAMES: Apo-Trimip; Rhotrimine; Stangyl; Sumontil; Surmontil (Odyssey)
- INDICATIONS: Major depression
- CLASS: Antidepressant; tricyclic
- HALF-LIFE: 20–26 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amprenavir, Arbutamine, Bupropion, Clonidine, Epinephrine, Formoterol, Guanethidine, Isocarboxazid, Linezolid, MAO inhibitors, Phenelzine, Quinolones, Sparfloxacin, Tranylcypromine, Venlafaxine
PREGNANCY CATEGORY: C
SUICIDALITY AND ANTIDEPRESSANT DRUGS
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric